Aspen Aerogels (NYSE: ASPN) reported Q1 EPS of ($0.39), $0.08 worse than the analyst estimate of ($0.31). Revenue for the quarter came in at $23 million versus the consensus estimate of $22.3 million.

For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.